Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laser Lipo Limited is a UK-based medical device company specializing in non-invasive aesthetic treatments, most notably the Strawberry Laser system. Founded in 2007, the company develops and manufactures low-level laser therapy (LLLT) devices designed for fat reduction, body contouring, and cellulite treatment. Its flagship products, including the Strawberry Inch Loss and Strawberry Lift systems, utilize non-thermal laser energy to stimulate the release of triglycerides from fat cells, providing a painless alternative to surgical liposuction. The company's technology is FDA-cleared and CE-marked, serving a global market of aesthetic clinics and medical spas. Laser Lipo continues to expand its portfolio with applications for submental fat reduction and skin tightening.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laser Lipo.